Dwight Moxie - Sep 14, 2022 Form 4 Insider Report for Revance Therapeutics, Inc. (RVNC)

Role
SVP, GC & Secretary
Signature
/s/ Dwight Moxie
Stock symbol
RVNC
Transactions as of
Sep 14, 2022
Transactions value $
-$297,798
Form type
4
Date filed
9/16/2022, 04:55 PM
Previous filing
Mar 17, 2022
Next filing
Mar 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Sale -$298K -11K -25.76% $27.07 31.7K Sep 14, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mr. Moxie.
F2 This transaction was executed in multiple trades at prices ranging from $26.76 to $27.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.